BRETEC Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Bioretec Oy - Alpha Spread
B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 2.72 EUR -0.73% Market Closed
Market Cap: 55.3m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Wall Street
Price Targets

BRETEC Price Targets Summary
Bioretec Oy

Wall Street analysts forecast BRETEC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRETEC is 3.06 EUR with a low forecast of 3.03 EUR and a high forecast of 3.15 EUR.

Lowest
Price Target
3.03 EUR
11% Upside
Average
Price Target
3.06 EUR
13% Upside
Highest
Price Target
3.15 EUR
16% Upside
Bioretec Oy Competitors:
Price Targets
7779
Cyberdyne Inc
51% Upside
041920
Mediana Co Ltd
312% Upside
SHL
Siemens Healthineers AG
19% Upside
ELN
El En SpA
30% Upside
PDEX
Pro-Dex Inc
23% Upside
STIL
Stille AB
24% Upside
AXDX
Accelerate Diagnostics Inc
13% Downside
DEMANT
Demant A/S
11% Upside

Revenue
Forecast

Revenue Estimate
Bioretec Oy

For the last 4 years the compound annual growth rate for Bioretec Oy's revenue is 22%. The projected CAGR for the next 3 years is 71%.

22%
Past Growth
71%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BRETEC's stock price target?
Price Target
3.06 EUR

According to Wall Street analysts, the average 1-year price target for BRETEC is 3.06 EUR with a low forecast of 3.03 EUR and a high forecast of 3.15 EUR.

What is Bioretec Oy's Revenue forecast?
Projected CAGR
71%

For the last 4 years the compound annual growth rate for Bioretec Oy's revenue is 22%. The projected CAGR for the next 3 years is 71%.

Back to Top